Transgene - Production Asset's Unit Acquisition

Transgene - Production Asset raised a round of funding on February 03, 2016. Investors include ABL.

Transgene (EPA:TNG) is a fully integrated biopharmaceutical company that designs and develops immunotherapeutic products to treat cancers and chronic infectious diseases. The Company's expertise cover…

Articles about Transgene - Production Asset's Unit Acquisition: